Selected article for: "early detection and gold standard"
Author: Lee, Cheryl Yi-Pin; Lin, Raymond T. P.; Renia, Laurent; Ng, Lisa F. P.
Title: Serological Approaches for COVID-19: Epidemiologic Perspective on Surveillance and Control
  • Cord-id: e2zjxjox
  • Document date: 2020_4_24
    • ID: e2zjxjox
    Snippet: Since December 2019, the novel coronavirus, SARS-CoV-2, has garnered global attention due to its rapid transmission, which has infected more than two million people worldwide. Early detection of SARS-CoV-2 is one of the crucial interventions to control virus spread and dissemination. Molecular assays have been the gold standard to directly detect for the presence of viral genetic material in infected individuals. However, insufficient viral RNA at the point of detection may lead to false negativ
    Document: Since December 2019, the novel coronavirus, SARS-CoV-2, has garnered global attention due to its rapid transmission, which has infected more than two million people worldwide. Early detection of SARS-CoV-2 is one of the crucial interventions to control virus spread and dissemination. Molecular assays have been the gold standard to directly detect for the presence of viral genetic material in infected individuals. However, insufficient viral RNA at the point of detection may lead to false negative results. As such, it is important to also employ immune-based assays to determine one's exposure to SARS-CoV-2, as well as to assist in the surveillance of individuals with prior exposure to SARS-CoV-2. Within a span of 4 months, extensive studies have been done to develop serological systems to characterize the antibody profiles, as well as to identify and generate potentially neutralizing antibodies during SARS-CoV-2 infection. The vast diversity of novel findings has added value to coronavirus research, and a strategic consolidation is crucial to encompass the latest advances and developments. This review aims to provide a concise yet extensive collation of current immunoassays for SARS-CoV-2, while discussing the strengths, limitations and applications of antibody detection in SARS-CoV-2 research and control.

    Search related documents:
    Co phrase search for related documents
    • accession number and acute phase: 1
    • accession number and acute respiratory syndrome: 1, 2, 3
    • accession number and acute respiratory syndrome coronavirus: 1, 2, 3
    • accuracy high sensitivity and acute phase: 1
    • accuracy high sensitivity and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • accuracy high sensitivity and acute respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8
    • accurate diagnosis and acid sample: 1, 2, 3, 4
    • accurate diagnosis and acute phase: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • accurate diagnosis and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • accurate diagnosis and acute respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acid sample and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acid sample and acute respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • active viral infection and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • active viral infection and acute respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8
    • actual day and acute respiratory syndrome: 1, 2, 3
    • actual day and acute respiratory syndrome coronavirus: 1, 2
    • acute phase and low degree: 1
    • acute respiratory syndrome and longitudinal profiling: 1
    • acute respiratory syndrome and low degree: 1, 2, 3, 4